ASCs Revising policy on new-technology IOLS
{"Image DocumentName": "ASCs Revising policy on new-technology IOLS", "Image ImageDescription": "FDA-approved label must contain a specific clinical benefit. Must be supported by evidence of improved outcomes. Proposed CF of   Up from   currently. See website for rates for specific procedures. 1.3 percent increase. No change in quality reporting. A few newly covered procedures.", "Image XResolution": "37", "Image YResolution": "37", "Image ResolutionUnit": "Pixels/Centimeter", "Image Software": "SlidePlayer", "Image YCbCrPositioning": "Centered"}